Ohio State University, U.S.
Brain Tumor Epidemiology Consortium formed to coordinate epidemiology studies on glioma
Published in Biotech Law Weekly, October 20th, 2006
According to recent research from the United States, "Gliomas account for almost 80% of primary malignant brain tumors, and they result in more years of life lost than do any other tumors. Glioblastoma, the most common type of glioma, is associated with very poor survival, so glioma epidemiology has focused on identifying factors that can be modified to prevent this disease."
"Only two relatively rare factors have so far been conclusively shown to affect glioma risk-exposure to high doses of ionizing radiation, and inherited mutations of highly penetrant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-10-20)
More Articles from Biotech Law Weekly
- Aastrom Biosciences
Aastrom Biosciences provides clinical, financial update - Auriga Laboratories
Auriga files drug-delivery patent application - Bioxel Pharma
Bioxel achieves key milestone in manufacturing of docetaxel - Cell Therapeutics
Cell Therapeutics announces licensing agreement with Novartis for Xyotax in treating NSCLC - Center for Addiction and Mental Health, Canada
Alcoholics Anonymous membership may decrease alcohol-related homicides - Drug Importation
Poll shows 80% of U.S. adults favor allowing importation of prescription drugs - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
